Novartis Investigative Site

Safed 13100

0 studies enrolling now · 2 studies all time

What they study most

Acute Decompensated Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction, Congestive Heart Failure

Studies at this site

• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed